Constitutive and inducible nitric oxide synthase: Role in angiogenesis

Antioxidants and Redox Signaling

Volumn 4, Issue 5, 2002, Pages 817-823

  Donnini, Sandra ^a   Ziche, Marina ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; FIBROBLAST GROWTH FACTOR 2; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CELL ACTIVATION; CELL DEATH; CELL PROLIFERATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0036775829     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308602760598972     Document Type: Review

References (54)

1. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am J Physiol 271: C1424-C1437, 1996.
2. Carmeliet F. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
3. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, and Keshert E, and Keshet E. Role of HIF-lalpha in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394: 485-490, 1998.
4. Cobbs CS, Brenman JE, Alpade KD, Bredt DS, and Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730, 1995.
5. Coffer PJ, Jin J, and Woodgett JR. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J335: 1-13, 1998.
6. Colasanti M and Suzuki H. The dual personality of NO. Trends Pharmacol Sci 21: 249-252, 2000.
7. Cornwell TL, Arnold E, Boerth NJ, and Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267: C1405-C1413, 1994.
8. Dimmeler S and Zeiher AM. Nitric oxide and apoptosis: And other paradigm for the double-edged role of nitric oxide. Nitric Oxide 1: 275-281, 1997.
9. Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, Ogawa M, and Maeda H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77: 1598-1604, 1996.
10. Ferrara N and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
11. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, and Ziche M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90: 587-596, 1998.
12. Garg UC and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
13. Haendeler J, Weiland U, Zeiher AM, and Dimmeler S. Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. Nitric Oxide 1: 282-293, 1997.
14. Hood JD, Meininger CJ, Ziche M, and Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274: H1054-H1058, 1998.
15. Jadeski LC, Hum KO, Chakraborty C, and Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 86: 30-39, 2000.
16. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, and Moncada S. Role of nitric oxide in tumor angiogenesis. Proc Natl Acad Sci USA 92: 4392-4396, 1995.
17. Kennovin GD, Hirst DG, Stratford MRL, and Flitney FW. Inducible nitric oxide synthase is expressed in tumor-associated vasculature: Inhibition retards tumors in vivo. Part 4, Enzymology, Biochemistry, and Immunology. Portland Press: London, 1994, pp. 473-479.
18. Klann E, Roberson ED, Knapp LT, and Sweatt JD. A role for superoxide in protein kinase C activation and induction of long-term potentiation. J Biol Chem 273: 4516-4522, 1998.
19. Klotz T, Bloch W, Volberg C, Engelmann U, and Addicks K. Selective expression of inducible nitric oxide synthase in human prostatic carcinoma. Cancer 82: 1897-1903, 1998.
20. Klotz T, Bloch W, Jacobs G, Niggermann S, Englemann U, and Addicks K. Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology 54: 416-419, 1999.
21. Ku DD, Zaleski JK, Lin S, and Brock TA. Vascular endothelial growth factor induces EDRF- dependent relaxation in coronary arteries. Am J Physiol 265: H586-H592, 1993.
22. Languino LR, Gehlsen KR, Wayner E, Carter WG, Engvall E, and Ruoslahti E. Endothelial cells use alpha 2 beta I integrin as a laminin receptor. J Cell Biol 109: 2455-2462, 1989.
23. Lee PC, Kibbe MR, Schucher MI, Stolz DB, Watkins SC, Griffith BP, Billiar TR, and Shears LL. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells. Microvasc Res 60: 269-280, 2000.
24. Li J, Billiar TR, Talanian RV, and Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240: 419-424, 1997.
25. Marshall HE, Merchant K, and Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J 14: 1889-1900, 2000.
26. Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
27. Morales-Ruiz M, Fulton D, Sowa G, Languino LR, Fujio Y, Walsh K, and Sessa WC. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 86: 892-896, 2000.
28. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, and Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 210: H411-H415, 1996.
29. Morbidelli L, Donnini S, and Ziche M. Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. Int J Biochem Cell Biol 33: 305-313, 2001.
30. Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F, and Ziche M. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol 124: 1286-1292, 1998.
31. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
32. Nathan C and Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728, 1994.
33. Noiri E, Hu Y, Bahou WF, Keese CR, Giaver I, and Goligorsky MS. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem 272: 1747-1752, 1997.
34. O'Donnell VB and Freeman BA. Interaction between nitric oxide and lipid oxidation pathway: Implication for vascular disease. Circ Res 88: 12-21, 2001.
35. Orucevic A and Lala PK. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumor growth in adenocarcinoma-bearing mice. Br J Cancer 73: 189-196, 1996.
36. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood J, Granger HJ, Ledda F, and Ziche M. Nitric oxide is an upstream signal for vascular endothelial growth factor-induced extracellular signal- regulated kinases-activation in postcapillary endothelium. J Biol Chem 273: 4220-4226, 1998.
37. Ramanujan S, Koenig GC, Padera TP, Stoll BR, and Jain RK. Local imbalance of proangiogenic and antiangiogenic factors: A potential mechanism of focal necrosis and dormancy in tumors. Cancer Res 60: 1442-1448, 2000.
38. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, and Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731-736, 1998.
39. Salom JB, Orti M, Centeno JM, Torregrosa G, and Alborch E. Reduction of infarct size by the NO donors sodium nitroprusside and spermine/NO after transient focal cerebral ischemia in rats. Brain Res 865: 149-156, 2000.
40. Sarkar R, Meinberg EG, Stanley JC, Gordon D, and Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78: 225-230, 1996.
41. Sato E, Simpson KL, Grisham MB, Koyama S, and Robbins RA. Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro. J Biol Chem 275: 10826-10830, 2000.
42. Seljelid R, Lozefowski S, and Sveinbjomsson B. Tumor stroma. Anticancer Res 19: 4809-4822, 1999.
43. Sen CK and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720, 1996.
44. Shizukuda Y, Tang S, Yokota R, and Ware JA. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity. Circ Res 85: 247-256, 1999.
45. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, and Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994.
46. Thomsen LL, Scott JMJ, Topley P, Knowles RG, Keerie AJ, and Frend AJ. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo. Studies with 1400W, a novel inhibitor. Cancer Res 57: 3300-3304, 1997.
47. Wu HM, Qiaobing H, Yuan Y, and Granger HJ. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol C1371-C1378, 1996.
48. Xie K and Fidler IJ. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 17: 55-75, 1998.
49. Xie K, Huang S, Dong Z, Juang S-H, Wang Y, and Fidler IJ. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. J Natl Cancer Inst 89: 421-427, 1997.
50. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y, Inoue N, Hirata K, Akita H, and Yokoyama M. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36: 97-102, 2000.
51. Yin JH, Yang DI, Ku G, and Hsu CY. iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem Biophys Res Commun 279: 30-34, 2000.
52. Ziche M, Morbidelli L, Parenti A, Amerini, S, Granger HI, and Maggi CA. Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells. Life Sci 53: 1105-1112, 1993.
53. Ziche M, Morbidelli L, Masini B, Amerini S, Granger HI, Maggi CA, Geppetti P, and Ledda E Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994.
54. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HI, and Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997.